Overview
Kyle Faget will be speaking on the FDA and DEA Regulation of Psychedelics – approaches to Schedule I Research and Approvals panel at IQVIA’s Controlled Substances & State Regulatory Conference, the industry’s premier annual gathering on controlled substance compliance. This conference will cover engaging discussions on the latest initiatives and challenges in controlled substance, listed chemical, and state regulatory compliance, featuring insights from regulatory authorities, law firms, and leading industry stakeholders.